CClinicalTrials.gg
CompletedNCT03161990Updated Jun 18, 2019

DAIR for Infected Total Hip Arthroplasty - Does the Operative Approach Influence the Functional Result?

An observational study in Hip Prosthesis Infection and Arthroplasty Complications, sponsored by University Hospital, Akershus. Completed at 1 site in Norway. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-06-18.

Sponsored by University Hospital, Akershus · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
226
Ages
18 Years and older
Sex
All
01

Study summary

The functional outcome and quality of life after treatment for an infected hip arthroplasty have been found to be significantly worse compared to an uncomplicated arthroplasty. However, the type of revision surgery chosen to treat the infection plays a role for the functional outcome. The concept of DAIR (debridement, antibiotics and implant retention) has been shown to yield god results with respect to infection control in cases of early infection with a stable implant and better functional results than a to-stage revision. In patients where infection control was achieved after just one DAIR procedure the functional outcome was comparable to an uncomplicated primary arthroplasty. However, it is not known if the operative approach used for the primary and revision surgery plays a role for the functional result after treatment of an infected total hip arthroplasty with DAIR. The project's aim is to investigate if the choice of the operative approach (transgluteal or posterior) for the primary hip replacement and the revision surgery has an influence on the functional result after debridement and implant retention for an infected total hip replacement.

Read the detailed description

Potential study participants will be identified in the Norwegian Arthroplasty Register. Patients who have been revised once for an infected total hip arthroplasty with debridement and implant retention and in whom either the transgluteal og posterior operative approach was used in both procedures will be selected. The potential participants will be contacted by letter. They will be asked for written informed consent and to fill out three questionnaires: the Hip Disability Osteoarthritis Score (HOOS), which also allows for the calculation of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC), the EQ-5D (quality of life) and a questionnaire asking about confirmation that the patient only has been revised once for his/her infected arthroplasty, about limping, other complications (nerve injury, dislocation, reoperation for other causes than infection), if the infection is considered to have been eradicated and overall satisfaction. The data recorded in the Norwegian Arthroplasty Register will be used in a multiple linear regression analysis to evaluate if the surgical approach is an independent factor influencing the outcome measures.

02

Conditions studied

  • Hip Prosthesis Infection
  • Arthroplasty Complications

Keywords

  • DAIR
  • Transgluteal approach
  • Posterior approach
03

In context

Lead sponsor

University Hospital, Akershus is the lead sponsor of 123 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The potential study participant will be identified in the Norwegian Arthroplasty Register.

Inclusion criteria

  • The infected total hip arthroplasty has only been revised once.
  • The revision procedure was a debridement and implant retention.
  • Both, the primary and the revision procedure were performed through the same surgical approach; either the transgluteal or the posterior approach.

Exclusion criteria

Exclusion Criteria:

  • No written informed consent.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
226 participants (actual)
Patient registry
No

Groups and cohorts

  • Transgluteal approach to the hip joint

    Patients who have been revised once for an infected total hip replacement with debridement and implant retention and in whom both the primary hip arthroplasty and the revision procedure were performed through a transgluteal approach.

    Procedure: Transgluteal approach to the hip joint

  • Posterior approach to the hip joint

    Patients who have been revised once for an infected total hip replacement with debridement and implant retention and in whom both the primary hip arthroplasty and the revision procedure were performed through a posterior approach.

    Procedure: Posterior approach to the hip joint

Interventions

  • ProcedureTransgluteal approach to the hip joint

    Operative approach to the hip joint where the abductors are partly detached from the greater trochanter and the hip joint is approached through the anterior part of the capsule.

    Also known as: Direct lateral approach to the hip joint

  • ProcedurePosterior approach to the hip joint

    Operative approach to the hip joint where the short external rotators are detached from the greater trochanter and the hip joint is approached through the posterior part of the capsule.

    Also known as: Posterolateral approach to the hip joint

06

What researchers measure

Primary outcomes

  1. Function subscale score of the WOMAC

    Function subscale score of the Western Ontario and McMaster Universities osteoarthritis index (WOMAC)

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

Secondary outcomes

  1. WOMAC score

    Western Ontario and McMaster Universities osteoarthritis index score

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

  2. HOOS

    Hip Disability Osteoarthritis Score

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

  3. EQ-5D score

    Quality of life score

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

  4. Limping

    Patient reported limping on the side of the revised total hip replacement.

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

  5. Other complications

    Patient reported nerve injury, dislocation, reoperation for other causes than infection.

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

  6. Overall satisfaction

    Overall satisfaction with the revised total hip replacement assessed by questionnaire.

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

Other outcomes

  1. Infection eradication

    Patient reported eradication of the infection of their total hip arthroplasty.

    Time frame: At minimum 1 year, on average 5 year follow-up from the DAIR procedure

07

Study locations

1 site
  • Akershus University hospital
    Lørenskog, 1478, Norway
08

References and documents

Publications

  • Cahill JL, Shadbolt B, Scarvell JM, Smith PN. Quality of life after infection in total joint replacement. J Orthop Surg (Hong Kong). 2008 Apr;16(1):58-65. doi: 10.1177/230949900801600115. PubMed 18453662 ↗
  • Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, Gundle R, Berendt A. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009 Jun;63(6):1264-71. doi: 10.1093/jac/dkp107. Epub 2009 Mar 31. Erratum In: J Antimicrob Chemother. 2011 May;66(5):1203. J Antimicrob Chemother. 2013 Dec;68(12):2964-5. PubMed 19336454 ↗
  • Grammatopoulos G, Kendrick B, McNally M, Athanasou NA, Atkins B, McLardy-Smith P, Taylor A, Gundle R. Outcome Following Debridement, Antibiotics, and Implant Retention in Hip Periprosthetic Joint Infection-An 18-Year Experience. J Arthroplasty. 2017 Jul;32(7):2248-2255. doi: 10.1016/j.arth.2017.02.066. Epub 2017 Mar 6. PubMed 28385345 ↗
  • Pollmann CT, Gjertsen JE, Dale H, Straume-Naesheim TM, Dybvik E, Hallan G. Operative approach influences functional outcome after DAIR for infected total hip arthroplasty. Bone Joint J. 2020 Dec;102-B(12):1662-1669. doi: 10.1302/0301-620X.102B12.BJJ-2020-0501.R1. PubMed 33249901 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03161990
Lead sponsor
University Hospital, Akershus
Collaborators
Haukeland University Hospital
Responsible party
Asbjorn Aroen (Professor, University Hospital, Akershus) — Principal investigator
First posted
May 22, 2017
Start date
Apr 23, 2018
Primary completion
Nov 17, 2018
Completion
Nov 17, 2018
Last update
Jun 18, 2019

Study contacts

Asbjorn Aaroen, Professor
study director · University Hospital, Akershus

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion